Portfolio Company

Monteris Medical

Monteris Medical develops and markets an FDA-cleared breakthrough robotically-controlled minimally-invasive neurosurgical system.

Learn More

Portfolio Company

Materna Medical

Materna Medical is a novel OB/GYN platform company dedicated to protecting and restoring women’s pelvic health.

Learn More

Portfolio Company

Route 92 Medical

Route 92 Medical is a medical technology company that is developing novel neuro-interventional technology with an initial application in stroke.

Learn More

Portfolio Company

Channel Medsystems

Channel Medsystems is an innovative Women’s Health company that offers an FDA-approved endometrial ablation device to treat heavy menstrual bleeding (HMB).

Learn More

Portfolio Company

Radiaction

Radiaction offers an automated system that substantially reduces radiation dose for all physicians and technicians in the interventional treatment suites.

Learn More

Portfolio Company

Koelis

Koelis is the leading innovator for image-guided systems for prostate cancer diagnosis and treatment. The Koelis Trinity™ System is a differentiated and versatile technology that enables urologists to more accurately diagnose prostate cancer and can offer patients a range of less invasive, non-radical treatment choices.

Learn More

Portfolio Company

OrthoSpace

OrthoSpace offers the first biodegradable subacromial balloon spacer, filling the gap in the shoulder continuum of care. The InSpace product is now FDA-cleared. Stryker acquired OrthoSpace in 2019.

Learn More

Portfolio Company

Blue Belt

Blue Belt offers the Navio surgical system, a robotic-assisted technology for use in orthopedic surgery and other specialties. Smith & Nephew acquired Blue Belt in 2015.

Learn More

Portfolio Company

ATEC

ATEC is focused on revolutionizing the approach to spine surgery in the U.S. and selective international markets. It acquired EOS Imaging in 2021. NASDAQ: ATEC

Learn More

IH Interests

Materna Medical Secures $20 Million Investment Led By InnovaHealth Partners

Learn More

Focus

InnovaHealth Partners is a New York City-based investment firm concentrating on growth buyouts of established medical technology companies. Our focus is on the highest growth and largest sectors of the medical device industry.

We partner with exceptional management teams to build innovative, differentiated and high-growth medical technology companies. Our investments address large unmet surgical needs on a global scale, meaningfully enhance patient outcomes and improve healthcare results on a sustainable basis.

With our expertise and relationships in major markets around the world, we identify later stage opportunities involving disruptive technologies. When combined with strong management, strategic insight and capital, the InnovaHealth portfolio companies unlock substantial value for all stakeholders.

Learn More

Strategy

InnovaHealth Partners invests in high-growth, established medical device companies primarily located in the United States, Europe and Israel. The firm targets medical technology companies with innovative products that address large unmet clinical needs, aiming to acquire controlling positions in its portfolio companies as the sole or lead investor.

Our portfolio companies gain more than just capital. The firm partners with management teams to accelerate growth and focus on value creation, leveraging longstanding relationships with strategic acquirers, clinical and scientific advisors, regulatory and reimbursement experts and industry executives to support these objectives. Together, we strive to develop technologies and build companies that will significantly advance patient care.

Portfolio Companies

Want to see where the InnovaHealth Partners team has previously succeeded with medical technology companies? Visit the portfolio pages to learn more.

Koelis

Koelis is a leadership innovator in image-guided systems for prostate cancer diagnosis and treatment.

Radiaction

Radiaction offers an automated system that substantially reduces radiation dose for all physicians and technicians in the interventional treatment suites.

Channel Medsystems

Channel Medsystems is an innovative Women’s Health company that offers an FDA-approved endometrial ablation device to treat heavy menstrual bleeding (HMB).